When a pharmaceutical company has discovered or invented a new medication to treat an illness, they must test the medication through a series of examinations, starting with phase i clinical trials and continuing until the drug is deemed safe for human use. In response to the question of what are clinical trials, they are simply a series of studies that examine how a specific drug works in humans, including all of the possible benefits and side effects. To provide a more clear understanding of how a drug comes to market, our website at DedicatedPhase1.com will look at all of the stages and levels of clinical research that are needed to fully test a drug before it becomes available.
Although phase i trials are the first step towards getting a drug accepted for general use, there are other steps that come between the invention of the product and these clinical study examinations. Before phase i trials can be started with humans, a company must provide information to regulatory bodies about the drug and receive approval to start the testing process. These regulations for medical research and clinical trials will vary from country to country, but should have the same goal of protecting the consumer from taking an ineffective or potentially dangerous medication.
The types of clinical trials vary wildly from case to case, with some early clinical trials being only a small study in a limited area and other phase 1 efforts including many people from various different global locations. One way to classify the different types of phase 1 efforts is as being observational or interventional. As the names would suggest, an observational study only involves watching the subjects while the interventional type usually has control groups to isolate the effects of a given medication. A more detailed way of looking at phase i tests is with the following classification groups: prevention trials, screening trials, diagnostic trials, treatment trials, quality of life trials, and compassionate use trials. This is a more complete system and looks at the total package of a new medication rather than just the ability to deal with a certain ailment.
One area where these types of tests are being used more frequently is in cancer research where new medications are being developed at a rapid pace to try and counter the effects of this varied condition. A large part of new drugs in cancer research never make it past the phase i stage because the problems they cause do more harm than good. Still, medical research companies spend billions of dollars each year in search of a potential cure for this problem. A person that would like to learn more about phase i clinical trials and the other important stages will find in DedicatedPhase1.com sections that provide all of this information.